NCT06162715
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
Active, Not Recruiting
PHASE2Ages 25–65InterventionalTreatmentVanderbilt University Medical CenterInvestigator-initiated
~30 participants
Updated 2026-08-04 on ClinicalTrials.gov
What's tested:TirzepatideStandard of Care post-gastric bypass
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Weight loss
Measured over baseline to 24 weeks
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesTennessee1
Study leadership
- Jason M Samuels, MD · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Weight lossbaseline to 24 weeks
Change in weight over time.
- Gastrointestinal symptomsbaseline to 24 weeks
We will measure the average PAGI SYM score from 0 - 24 weeks in both arms.